Align Technology
ALGN · NASDAQ · Healthcare
$148.17
+$1.30 (+0.88%) today
Market Cap
$10.53B
24h Volume
$195.7M
P/E Ratio
25.7
52w High
$197.51
52w Low
$124.88
Est. AI Revenue
18%
7-Day Sparkline (Static)
Company facts
Performance
About Align Technology
Align Technology makes Invisalign, the clear aligner system for straightening teeth, along with iTero intraoral scanners. It earns revenue selling aligners and scanners to orthodontists and dentists, who use them to plan and deliver treatment.
AI supports the clinical workflow. ClinCheck uses AI in treatment planning, the iTero scanner applies AI to 3D imaging of teeth, AI Smile Design simulates outcomes for patients, and digital treatment planning tools help doctors map tooth movement before treatment begins.
Founded in 1997 and headquartered in Tempe, Arizona, Align trades on the NASDAQ and employs about 20,290 people.
Align Technology in the AI buildout
Align sits in the AI Healthcare layer of the buildout as an adopter that embeds AI into dental hardware and software. Its AI treatment planning and smile simulation improve clinical workflow and help convert patients into treatment, which supports its aligner and scanner franchise. Revenue ultimately depends on consumer demand for orthodontics, leaving AI as a supporting tool, which is why Supercycle scores its exposure at 15 out of 100.
ALGN is tracked in AI Healthcare, rated Peripheral on the AI Exposure leaderboard.
By the numbers
52-week range
ALGN trades at $148.17, 32% of the way up its 52-week range of $124.88 to $197.51.
Market cap
Market capitalization is $10.53B, with an AI Exposure Score of 15 out of 100.
Valuation vs peers
Its P/E ratio of 25.7 is in line with the AI Healthcare category median of 29.6.
Next earnings
Align Technology is next expected to report earnings on October 28, 2026.
Market data as of the close on . Prices are end of day, not live.
Frequently asked questions
What does Align Technology do?
Align makes the Invisalign clear aligner system and iTero intraoral scanners. Orthodontists and dentists buy its products to scan patients, plan treatment digitally, and straighten teeth without traditional braces.
How is Align Technology exposed to AI?
As a supporting tool. AI improves treatment planning and patient conversion, but revenue depends on consumer demand for orthodontic treatment. Supercycle gives it an AI Exposure Score of 15 out of 100.
What are Align's main AI products?
ClinCheck AI treatment planning, the iTero AI scanner for 3D dental imaging, AI Smile Design that simulates treatment outcomes, and digital treatment planning tools that map tooth movement in advance.
Where is Align headquartered and who leads it?
Align is headquartered in Tempe, Arizona, and led by CEO Joe Hogan. The company was founded in 1997, employs about 20,290 people, and its shares trade on the NASDAQ.
Is ALGN a pure play AI stock?
No. Align is a dental products company that uses AI to improve clinical workflows around Invisalign and iTero. Its AI Exposure Score of 15 out of 100 sits toward the lower end of the leaderboard.
Profile written 2026-08, updated as the business changes. Editorial content, not investment advice.